Volume | 2,600,124 |
|
|||||
News | - | ||||||
Day High | 9.96 | Low High |
|||||
Day Low | 8.43 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
CareDx Inc | CDNA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
8.51 | 8.43 | 9.96 | 9.18 | 7.76 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
25,062 | 2,600,124 | US$ 9.08 | US$ 23,620,966 | - | 4.80 - 12.93 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
17:13:00 | 1 | US$ 9.18 | USD |
CareDx Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
475.84M | 51.78M | - | 280.32M | -190.28M | -3.68 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
CareDx News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDNA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.20 | 9.96 | 7.42 | 7.84 | 672,269 | 0.98 | 11.95% |
1 Month | 9.84 | 10.30 | 7.42 | 8.50 | 627,550 | -0.66 | -6.71% |
3 Months | 8.99 | 12.8337 | 7.42 | 9.68 | 785,829 | 0.19 | 2.11% |
6 Months | 5.53 | 12.93 | 5.20 | 9.55 | 1,036,944 | 3.65 | 66.00% |
1 Year | 8.10 | 12.93 | 4.80 | 9.01 | 936,907 | 1.08 | 13.33% |
3 Years | 79.78 | 96.88 | 4.80 | 23.42 | 893,684 | -70.60 | -88.49% |
5 Years | 27.41 | 99.83 | 4.80 | 28.94 | 821,093 | -18.23 | -66.51% |
CareDx Description
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden. |